Ernexa Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,521 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 601-625 of 1,000 matching filings.

Per page
25
Current page
25
4

4 filing

Filing date
20 Dec 2018
Reporting date
19 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Dec 2018
Reporting date
19 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Dec 2018
Reporting date
19 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-42217

SCHEDULE 13D

Filing date
17 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K filing

Filing date
17 Dec 2018
Reporting date
14 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K filing

Filing date
07 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-42217

SC 13D

Filing date
21 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Nov 2018
Reporting date
20 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Nov 2018
Reporting date
20 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Nov 2018
Reporting date
20 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-11460

10-Q filing

Filing date
09 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
8-K File 001-11460

8-K filing

Filing date
07 Nov 2018
Reporting date
07 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Oct 2018
Reporting date
23 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Oct 2018
Reporting date
23 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Oct 2018
Reporting date
23 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K filing

Filing date
01 Oct 2018
Reporting date
28 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Sep 2018
Reporting date
25 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Sep 2018
Reporting date
25 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Sep 2018
Reporting date
25 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-11460

10-Q filing

Filing date
06 Aug 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
8-K File 001-11460

8-K filing

Filing date
02 Aug 2018
Reporting date
02 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-42217

NTN BUZZTIME

Filing date
09 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-42217

SC 13D/A filing

Filing date
02 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K filing

Filing date
29 Jun 2018
Reporting date
29 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-215271

424B5 filing

Filing date
27 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .